Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

04/02/2020 06:00

Feb 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2019        Dec 31, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             8.49                8.09              11.30     
                 (+5.0 pct)          (-3.6 pct)        (+5.2 pct)   
  Operating     loss 859 mln           67 mln         loss 900 mln  
                                    (+849.4 pct)                    
  Recurring     loss 818 mln           102 mln        loss 900 mln  
                                    (+246.3 pct)                    
  Net             loss 1.56            191 mln          loss 1.65   
  EPS          loss 44.93 yen         5.53 yen       loss 47.54 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T